Design Therapeutics, Inc.
DSGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $15 | $20 | $14 | $23 |
| Short-Term Investments | $191 | $197 | $216 | $223 |
| Receivables | $1 | $1 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $2 | $3 | $1 |
| Total Curr. Assets | $209 | $220 | $234 | $248 |
| Property Plant & Equip (Net) | $3 | $3 | $3 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $3 | $3 | $4 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $212 | $223 | $237 | $252 |
| Liabilities | – | – | – | – |
| Payables | $2 | $1 | $3 | $2 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8 | $7 | $4 | $5 |
| Total Curr. Liab. | $11 | $9 | $8 | $8 |
| LT Debt | $1 | $1 | $1 | $2 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $1 | $1 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $2 | $2 | $2 |
| Total Liabilities | $12 | $10 | $10 | $10 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$281 | -$264 | -$245 | -$227 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $480 | $477 | $472 | $469 |
| Total Equity | $200 | $213 | $228 | $242 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $212 | $223 | $237 | $252 |
| Net Debt | -$13 | -$18 | -$12 | -$20 |